These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18829251)

  • 21. Monitoring systemic complications of intraocular medications.
    Pulido JS
    Can J Ophthalmol; 2010 Jun; 45(3):215-7. PubMed ID: 20628419
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute renal failure in a patient receiving anti-VEGF therapy for advanced non-small cell lung cancer.
    Zhao J; Li H; Wang M
    J Thorac Oncol; 2009 Sep; 4(9):1185-7. PubMed ID: 19704343
    [No Abstract]   [Full Text] [Related]  

  • 23. Bevacizumab + sunitinib: microangiopathic haemolytic anaemia. A serious drug interaction between 2 cancer drugs.
    Prescrire Int; 2009 Aug; 18(102):165. PubMed ID: 19746526
    [No Abstract]   [Full Text] [Related]  

  • 24. Angiotensin-converting enzyme inhibitors for bevacizumab-induced hypertension.
    Dincer M; Altundag K
    Ann Pharmacother; 2006 Dec; 40(12):2278-9. PubMed ID: 17105834
    [No Abstract]   [Full Text] [Related]  

  • 25. Bevacizumab in the treatment of breast cancer.
    Koutras AK; Fountzilas G; Makatsoris T; Peroukides S; Kalofonos HP
    Cancer Treat Rev; 2010 Feb; 36(1):75-82. PubMed ID: 19932567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case of anterior uveitis after intravitreal injection of bevacizumab.
    Pieramici DJ; Avery RL; Castellarin AA; Nasir MA; Rabena M
    Retina; 2006 Sep; 26(7):841-2. PubMed ID: 16963867
    [No Abstract]   [Full Text] [Related]  

  • 27. Bevacizumab-induced cardiovascular events: a consequence of cholesterol emboli syndrome?
    Mir O; Mouthon L; Alexandre J; Mallion JM; Deray G; Guillevin L; Goldwasser F
    J Natl Cancer Inst; 2007 Jan; 99(1):85-6. PubMed ID: 17202119
    [No Abstract]   [Full Text] [Related]  

  • 28. What we don't know about avastin might hurt us.
    Gillies MC
    Arch Ophthalmol; 2006 Oct; 124(10):1478-9. PubMed ID: 17030717
    [No Abstract]   [Full Text] [Related]  

  • 29. Preretinal neovascularization after bevacizumab injections in a patient with von Hippel-Lindau syndrome.
    Walker RA; Colleaux KM
    Can J Ophthalmol; 2009 Oct; 44(5):608-9. PubMed ID: 19789606
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravitreal bevacizumab (Avastin) treatment is safe in terms of intraocular and blood pressure.
    Kernt M; Neubauer AS; Kampik A
    Acta Ophthalmol Scand; 2007 Feb; 85(1):119-20. PubMed ID: 17244226
    [No Abstract]   [Full Text] [Related]  

  • 31. Early loss of pregnancy after intravitreal bevacizumab injection.
    Petrou P; Georgalas I; Giavaras G; Anastasiou E; Ntana Z; Petrou C
    Acta Ophthalmol; 2010 Jun; 88(4):e136. PubMed ID: 19740128
    [No Abstract]   [Full Text] [Related]  

  • 32. Systemic adverse events after bevacizumab.
    Roth DB; King A; Weiss M; Klein D
    Ophthalmology; 2009 Jun; 116(6):1226.e1. PubMed ID: 19486800
    [No Abstract]   [Full Text] [Related]  

  • 33. Bevacizumab in breast cancer: the best is yet to come?
    Puhalla S; Brufsky A
    Oncology (Williston Park); 2009 Apr; 23(4):332, 335. PubMed ID: 19476262
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer.
    Sandler AB; Johnson DH; Herbst RS
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4258s-4262s. PubMed ID: 15217970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endophthalmitis after anti-VEGF injections.
    Klein KS; Walsh MK; Hassan TS; Halperin LS; Castellarin AA; Roth D; Driscoll S; Prenner JL
    Ophthalmology; 2009 Jun; 116(6):1225.e1. PubMed ID: 19486799
    [No Abstract]   [Full Text] [Related]  

  • 36. Optimizing outcomes with bevacizumab by better targeting patients and tumors.
    DeMichele A; Fox KR
    Oncology (Williston Park); 2009 Apr; 23(4):339-40. PubMed ID: 19476263
    [No Abstract]   [Full Text] [Related]  

  • 37. Sixth nerve palsy post intravitreal bevacizumab for AMD: a new possibly causal relationship and complication?
    Park HJ; Guy J
    Binocul Vis Strabismus Q; 2007; 22(4):209. PubMed ID: 18163895
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical use of anti-vascular endothelial growth factor monoclonal antibodies in metastatic colorectal cancer.
    Chase JL
    Pharmacotherapy; 2008 Nov; 28(11 Pt 2):23S-30S. PubMed ID: 18980549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular toxicity of new agents.
    Maitland ML
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):657-9. PubMed ID: 18827788
    [No Abstract]   [Full Text] [Related]  

  • 40. Reversible skeletal changes after treatment with bevacizumab in a child with cutaneovisceral angiomatosis with thrombocytopenia syndrome.
    Smith AR; Hennessy JM; Kurth MA; Nelson SC
    Pediatr Blood Cancer; 2008 Sep; 51(3):418-20. PubMed ID: 18493993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.